Ganga Pharmaceuticals Ltd.
| BSE: 539680 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE615T01017 |
| BSE 00:00 | 02 Feb | 7.50 |
0 (0.00%) |
OPEN
7.50 |
HIGH
7.50 |
LOW
7.50 |
| NSE 05:30 | 01 Jan | Ganga Pharmaceuticals Ltd |
| OPEN | 7.50 |
| PREVIOUS CLOSE | 7.50 |
| VOLUME | 8000 |
| 52-Week high | 12.00 |
| 52-Week low | 7.05 |
| P/E | 16.30 |
| Mkt Cap.(Rs cr) | 3 |
| Buy Price | 8.64 |
| Buy Qty | 8000.00 |
| Sell Price | 9.00 |
| Sell Qty | 8000.00 |
Ganga Pharmaceuticals Ltd. (GANGAPHARMA) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 880.80 | -5.95 | -0.67 | 13266.48 |
| Cipla | 812.30 | 0.20 | 0.02 | 12659.15 |
| Sun Pharma.Inds. | 624.15 | 9.75 | 1.59 | 12531.93 |
| Dr Reddy's Labs | 4500.80 | 94.60 | 2.15 | 11850.40 |
| Lupin | 1060.85 | 6.25 | 0.59 | 11025.66 |
| Apollo Hospitals | 3058.15 | -31.60 | -1.02 | 9794.50 |
| Glenmark Pharma. | 479.00 | 2.80 | 0.59 | 6712.63 |
| Alkem Lab | 2840.90 | -69.25 | -2.38 | 6677.08 |
| Cadila Health. | 445.50 | 4.55 | 1.03 | 6347.40 |
| Torrent Pharma. | 2497.45 | 28.50 | 1.15 | 6168.44 |
| Divi's Lab. | 3565.10 | 49.55 | 1.41 | 5310.57 |
| Ipca Labs. | 1961.25 | 55.10 | 2.89 | 4337.82 |
| Piramal Enterp. | 1992.70 | 74.70 | 3.89 | 4219.19 |
| Alembic Pharma | 929.20 | -5.85 | -0.63 | 4132.55 |
| Abbott India | 14609.05 | 86.85 | 0.60 | 4093.14 |
| Glaxosmi. Pharma | 1524.50 | 57.40 | 3.91 | 3224.68 |
| Jubilant Pharmo | 789.40 | 9.30 | 1.19 | 3139.90 |
| Sanofi India | 8293.80 | -32.75 | -0.39 | 3070.60 |
| Laurus Labs | 364.60 | 2.55 | 0.70 | 2797.34 |
| Gland Pharma | 2432.70 | 82.75 | 3.52 | 2633.24 |
Quick Links for Ganga Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
